Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Research & Development (2010 - 2026)

Geron's (GERN) quarterly Research & Development came in at $22.0 million in Q2 2026, up 1.35% year-over-year from $21.7 million in Q2 2025, and up 47.3% quarter-over-quarter from $15.0 million in Q1 2026.

Analysis

Geron (GERN) Research & Development (2010 - 2026) Analysis & Trends

Geron has disclosed Research & Development across 17 years of filings, most recently posting $22.0 million for Q2 2026.

  • In Q2 2026, Research & Development rose 1.35% year-over-year to $22.0 million; the TTM figure through Jun 2026 stood at $71.6 million (down 10.94% YoY), while the FY2025 annual figure was $71.4 million, down 31.14% from the prior year.
  • Research & Development came in at $22.0 million for Q2 2026 at Geron, up from $15.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $35.5 million in Q2 2023 to a low of $13.5 million in Q4 2025.
  • Average Research & Development over 5 years is $24.0 million, with a median of $22.8 million recorded in 2022.
  • Year-over-year, Research & Development surged 72.23% in 2023 and tumbled 48.67% in 2025.
  • Over 5 years, Research & Development stood at $28.2 million in 2022, then increased by 16.66% to $32.9 million in 2023, then declined by 28.8% to $23.4 million in 2024, then tumbled by 42.18% to $13.5 million in 2025, then soared by 62.6% to $22.0 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $22.0 million in Q2 2026, $15.0 million in Q1 2026, and $13.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -486.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 202.02 Mn
10 Geron 914.60 Mn 613.75 Mn - 22.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.03 Mn
Mar 31, 2026 14.96 Mn
Dec 31, 2025 13.55 Mn
Sep 30, 2025 21.07 Mn
Jun 30, 2025 21.74 Mn
Mar 31, 2025 15.08 Mn
Dec 31, 2024 23.43 Mn
Sep 30, 2024 20.15 Mn
Jun 30, 2024 30.78 Mn
Mar 31, 2024 29.37 Mn
Dec 31, 2023 32.91 Mn
Sep 30, 2023 29.43 Mn
Jun 30, 2023 35.49 Mn
Mar 31, 2023 27.22 Mn
Dec 31, 2022 28.21 Mn
Sep 30, 2022 24.60 Mn
Jun 30, 2022 20.61 Mn
Mar 31, 2022 22.10 Mn
Dec 31, 2021 24.15 Mn
Sep 30, 2021 18.53 Mn